Proposed changes to management of lower respiratory tract infections in response to the Clostridium difficile epidemic
Open Access
- 23 February 2010
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 65 (4) , 608-618
Abstract
Clostridium difficile infection (CDI) remains a major healthcare problem associated with antibiotic use in hospitals. Recent years have seen a dramatic increase in the incidence of CDI in the UK and internationally. Lower respiratory tract infections (LRTIs) are the leading indication for antibiotic prescription in hospitals and are therefore a critical battleground in the fight against inappropriate antibiotic use and healthcare-associated infections. This article reviews the evidence for interventions to reduce CDI in hospitalized patients with LRTIs. Reducing prescriptions of cephalosporins and fluoroquinolones in favour of penicillin-based regimens and increased use of tetracyclines have been proposed. Expanding outpatient management of LRTIs and reducing length of hospital stay will limit patient exposure to the healthcare environment in which C. difficile is most easily acquired. Intravenous (iv) broad-spectrum antibiotics are often prescribed when narrower spectrum, oral antimicrobials would be equally effective and, in a proportion of patients, antibiotic therapy is used unnecessarily. Shorter antibiotic regimes may be as effective as prolonged therapy and reduce antibiotic-related complications. Early switch from iv to oral therapy allows simpler antibiotic regimens and facilitates early discharge from hospital. Simple improvements in the management of LRTIs have the potential to reduce the incidence of healthcare-associated infections.Keywords
This publication has 87 references indexed in Scilit:
- Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trialsCanadian Medical Association Journal, 2008
- Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infectionCanadian Medical Association Journal, 2008
- Comparison of β-Lactam and Macrolide Combination Therapy versus Fluoroquinolone Monotherapy in Hospitalized Veterans Affairs Patients with Community-Acquired PneumoniaAntimicrobial Agents and Chemotherapy, 2007
- Community-acquired pneumonia: doctors do not follow national guidelinesPostgraduate Medical Journal, 2007
- Effect of Fluoroquinolone Treatment on Growth of and Toxin Production by Epidemic and Nonepidemic Clostridium difficile Strains in the Cecal Contents of MiceAntimicrobial Agents and Chemotherapy, 2007
- The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumoniaThorax, 2007
- Prospective comparison of three predictive rules for assessing severity of community-acquired pneumonia in Hong KongThorax, 2007
- Reducing door-to-antibiotic time in community-acquired pneumonia: controlled before-and-after evaluation and cost-effectiveness analysisThorax, 2007
- Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trialBMJ, 2006
- Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind studyBMJ, 2006